Shaedon Sharpe's Torn Meniscus Could Sideline Blazers Guard Six Months

Shaedon Sharpe tore the meniscus in his right knee during a workout in Portland, a league source said, and the Trail Blazers guard is expected to miss around six months as he continues to battle a pattern of injuries that has followed him since he entered the league. The 23-year-old is one of Portland's best players at creating his own shot and one of the NBA's best leapers, but his availability has become an increasingly urgent concern for a franchise that just committed nine figures to keep him long term.

According to The Athletic, Sharpe suffered the injury during a workout, and the timeline of roughly six months comes per ESPN. The Athletic's Jason Quick reports that the Trail Blazers will wait for a further assessment before determining Sharpe's exact timeline. That reported recovery window is consistent with what's typically required for a full meniscus repair rather than a partial meniscectomy, according to Johns Hopkins Medicine, which notes that a partial meniscectomy typically allows athletes back on the court within four to eight weeks. A six-month timeline signals surgeons opted to preserve the joint tissue rather than remove it, prioritizing Sharpe's long-term knee health over a faster return.

A Troubling Pattern of Setbacks

This is far from Sharpe's first bout with injury. He missed 28 games last season because of a stress fracture in his left tibia, per the same Athletic report, and has torn the labrum in his left shoulder twice over his career. In his second season, an abdominal injury limited him to just 32 games. Across his four years in the league, the report's numbers show Sharpe has averaged only 58.5 games per season.

Even before this latest injury, Sharpe wasn't at full strength. The Rip City Project's Rip City Project reported that he was limited to just 7.2 points in 13.4 minutes per game during Portland's five-game playoff series against the San Antonio Spurs early this year after suffering a late-season leg injury. He returned to action for only Portland's final two regular-season games after missing nearly two months with the left fibula injury, according to Sportsnet.

The Production Portland Will Miss

When healthy, Sharpe has been a legitimate offensive force. He played 50 games last season and averaged a career-high 20.8 points and 4.3 rebounds, with his scoring jumping to 21.9 points per game as a starter compared to 15.4 as a reserve, per Sportsnet's reporting. For his career, Sharpe carries averages of 15.7 points and 4.0 rebounds, and the Trail Blazers selected him seventh overall in the 2022 NBA Draft.

Portland made its long-term bet on Sharpe clear in October 2025, when he signed a four-year, $90 million rookie scale contract extension running through the 2029-30 season. The deal is projected to consume roughly 12% to 13% of the NBA salary cap annually over its four-year span, the Rip City Project has noted. On that same day, Portland also locked up defensive wing Toumani Camara on a four-year, $82 million extension, underscoring how the front office has tried to secure its young core for the long haul.

Easing — But Not Solving — a Backcourt Crunch

The timing of Sharpe's injury creates an odd silver lining for Portland's rotation math. His absence will ease the Trail Blazers' guard logjam, since the roster currently features Damian Lillard, Ja Morant, Scoot Henderson and Jrue Holiday all expected to command playing time in the backcourt. All four of those guards measure 6-foot-4 or shorter, according to community reporting on r/NBADaily, which had highlighted how Sharpe's 6-foot-5 frame and leaping ability offered the roster size it otherwise lacks on the perimeter.

That logjam grew significantly more crowded in June, when Portland acquired All-Star guard Morant from the Memphis Grizzlies in exchange for Jerami Grant and Kris Murray. Sharpe had been expected to be a key rotation piece for coach Chauncey Billups regardless of the additions, and his layoff now leaves open questions about how those backcourt minutes get divided in his absence — and whether Portland's front office looks to further reshape the roster before he targets a return.

Sharpe's ties to Portland's storylines this season have been well documented; Hoodline previously covered how Sharpe surfaced in Giannis trade buzz as a potential young trade asset for the franchise. For now, though, the immediate story is medical rather than transactional: a talented, still-developing guard facing another extended stretch on the sideline as Portland tries to figure out its identity around him.